Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13G/A | 2024-03-27 | INGALLS & SNYDER LLC | CORCEPT THERAPEUTICS INC | 8,262,476 | 8.0% | EDGAR |
SC 13G/A | 2024-02-14 | BAKER G LEONARD JR | CORCEPT THERAPEUTICS INC | 5,512,696 | 5.3% | EDGAR |
SC 13G/A | 2024-02-13 | RENAISSANCE TECHNOLOGIES LLC | CORCEPT THERAPEUTICS INC | 6,725,871 | 6.5% | EDGAR |
SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | CORCEPT THERAPEUTICS INC | 9,537,532 | 9.2% | EDGAR |
SC 13G/A | 2024-02-12 | BELANOFF JOSEPH K | CORCEPT THERAPEUTICS INC | 6,581,918 | 6.1% | EDGAR |
SC 13G/A | 2024-01-22 | BlackRock Inc. | CORCEPT THERAPEUTICS INC | 16,407,696 | 15.9% | EDGAR |
SC 13G/A | 2023-02-17 | INGALLS & SNYDER LLC | CORCEPT THERAPEUTICS INC | 7,090,370 | 6.6% | EDGAR |
SC 13G/A | 2023-02-15 | BELANOFF JOSEPH K | CORCEPT THERAPEUTICS INC | 6,081,918 | 5.5% | EDGAR |
SC 13G/A | 2023-02-14 | BAKER G LEONARD JR | CORCEPT THERAPEUTICS INC | 5,485,196 | 5.1% | EDGAR |
SC 13G/A | 2023-02-13 | RENAISSANCE TECHNOLOGIES LLC | CORCEPT THERAPEUTICS INC | 7,288,871 | 6.8% | EDGAR |
SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | CORCEPT THERAPEUTICS INC | 10,345,030 | 9.6% | EDGAR |
SC 13G/A | 2023-01-26 | BlackRock Inc. | CORCEPT THERAPEUTICS INC | 16,347,383 | 15.2% | EDGAR |
SC 13G | 2023-01-20 | BlackRock Inc. | CORCEPT THERAPEUTICS INC | 16,347,383 | 15.2% | EDGAR |
SC 13G/A | 2022-03-09 | VANGUARD GROUP INC | CORCEPT THERAPEUTICS INC | 10,844,789 | 10.2% | EDGAR |
SC 13G | 2022-02-14 | BAKER G LEONARD JR | CORCEPT THERAPEUTICS INC | 5,465,196 | 5.2% | EDGAR |
SC 13G/A | 2022-02-11 | RENAISSANCE TECHNOLOGIES LLC | CORCEPT THERAPEUTICS INC | 8,023,616 | 7.0% | EDGAR |
SC 13G/A | 2022-02-11 | BELANOFF JOSEPH K | CORCEPT THERAPEUTICS INC | 6,374,376 | 5.8% | EDGAR |
SC 13G/A | 2022-02-09 | VANGUARD GROUP INC | CORCEPT THERAPEUTICS INC | 10,797,477 | 9.4% | EDGAR |
SC 13G/A | 2022-02-04 | INGALLS & SNYDER LLC | CORCEPT THERAPEUTICS INC | 6,655,977 | 5.7% | EDGAR |
SC 13G/A | 2022-01-28 | BlackRock Inc. | CORCEPT THERAPEUTICS INC | 15,047,993 | 13.0% | EDGAR |